3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
This page is not indexed by search engines while we improve data quality.
Shultz Michael David — Human Necessities
Shultz Michael David holds 10 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Shultz Michael David |
| Technology | Human Necessities |
| Patents in slice | 10 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2016 |
Representative patents
Notable publications linking Shultz Michael David to Human Necessities.
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
Recent filings
Latest patents from Shultz Michael David in Human Necessities.
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
US-2016318915-A1 · Nov 3, 2016 · US
Related pages
Navigate to parent entity pages.